Literature DB >> 9037371

Cellular factors as alternative targets for inhibition of HIV-1.

M Baba1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9037371     DOI： 10.1016/s0166-3542(96)01010-8

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  6 in total

1.  Ethyl 4-(3-hydroxy-phen-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate.

Authors:  P Mookiah; K Rajesh; T Narasimhamurthy; V Vijayakumar; N Srinivasan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-07

2.  Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action.

Authors:  Miguel Stevens; Christophe Pannecouque; Erik De Clercq; Jan Balzarini
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

3.  Ethyl 2-methyl-5-oxo-4-(3,4,5-trimeth-oxy-phen-yl)-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate.

Authors:  S Natarajan; P Indumathi; B Palakshi Reddy; V Vijayakumar; P L Nilantha Lakshman
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

4.  Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication.

Authors:  Thomas Cherrier; Mikael Elias; Alicia Jeudy; Guillaume Gotthard; Valentin Le Douce; Houda Hallay; Patrick Masson; Andrea Janossy; Ermanno Candolfi; Olivier Rohr; Eric Chabrière; Christian Schwartz
Journal:  Virol J       Date:  2011-07-15       Impact factor: 4.099

Review 5.  Achieving a cure for HIV infection: do we have reasons to be optimistic?

Authors:  Valentin Le Douce; Andrea Janossy; Houda Hallay; Sultan Ali; Raphael Riclet; Olivier Rohr; Christian Schwartz
Journal:  J Antimicrob Chemother       Date:  2012-02-01       Impact factor: 5.790

Review 6.  Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.

Authors:  Moshe Rogosnitzky; Paul Okediji; Igor Koman
Journal:  Pharmacol Rep       Date:  2020-07-22       Impact factor: 3.024
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.